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1. Introduction
Considerable changes in calcium homeostasis occur during
pregnancy to meet the demands of the fetus. The fetal skeleton
contains approximately 30 g of calcium at birth [1]. These changes
are particularly evident in the third trimester, when almost
250 mg/day of calcium is transferred from mother to fetus [2].
Increased intestinal absorption is the main mechanism for
supplying the increased demand for calcium [3]. Vitamin D and
its active metabolite, 1,25(OH)2D, are the essential elements for
intestinal calcium uptake. The concentration of 1,25(OH)2D
increases by 50–100% during the second trimester and 100% by
the third trimester [4]. At present, the general recommendation for
administration of vitamin D in pregnant women is 400 U/day.
Some studies have shown, however, that this amount of vitamin D
is insufﬁcient during gestation, and higher doses are needed to
prevent the complications associated with vitamin D deﬁciency
during pregnancy [5].
Studies on pregnant women have demonstrated a high
prevalence of vitamin D deﬁciency worldwide, particularly in
developing countries and in women of Asian ethnicity [6–9].
Reports from Iran have shown vitamin D deﬁciency in 40–80% of
pregnant women during different seasons of the year [10,11].
Descriptive studies have reported correlation between vitamin D
deﬁciency and maternal complications (e.g. pre-eclampsia [12],
decreased fertility [13] and increased bone resorption markers
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A B S T R A C T
Objective: To determine whether treatment of low serum vitamin D in pregnant women improves fetal
growth indices.
Study design: In this open-label randomized clinical trial, 130 Iranian pregnant women (24–26 weeks of
gestation) with vitamin D deﬁciency or insufﬁciency [25(OH)D <30 ng/ml] were divided at random into
an intervention group and a control group. The control group received 200 mg calcium plus a
multivitamin (containing vitamin D3 400 U) each day, and the intervention group received 200 mg
calcium plus a multivitamin (containing vitamin D3 400 U) each day, plus vitamin D3 (50,000 U) each
week for 8 weeks. At delivery, maternal and cord blood 25(OH)D levels, maternal weight gain, neonatal
length, neonatal weight and neonatal head circumference were compared between two groups. Serum
vitamin D was measured using enzyme-linked immunosorbent assay. A multivariate regression analysis
was performed to examine the independent effect of maternal vitamin D level on fetal growth indices.
Results: Mean (standard deviation) length (intervention group: 49  1.6 cm; control group: 48.2  1.7 cm;
p = 0.001), head circumference (intervention group: 35.9  0.7 cm; control group: 35.3  1.0 cm; p = 0.001)
and weight (intervention group: 3429  351.9 g; control group: 3258.8  328.2 g; p = 0.01) were higher in
the intervention group compared with the control group. Mean maternal weight gain was higher in the
intervention group compared with the control group (13.3  2.4 kg vs 11.7  2.7 kg; p = 0.006). Multivariate
regression analysis for maternal weight gain, neonatal length, neonatal weight and neonatal head
circumference showed an independent correlation with maternal vitamin D level.
Conclusion: Treatment of low serum vitamin D during pregnancy improves fetal growth indices and
maternal weight gain.
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[14]) and fetal complications (e.g. higher risk of infection [15],
neonatal hypocalcaemia [16] and craniotabes [17]), but ﬁndings
regarding the association between vitamin D deﬁciency and
decreased fetal growth indices are inconsistent [18–21]. Maternal
ultraviolet B exposure is positively associated with bone mineral
content and bone size of infants, suggesting that maternal vitamin
D has a direct effect on periosteal bone formation of infants [22]. An
association between low maternal vitamin D in late pregnancy and
reduced intrauterine long bone growth has been reported [20].
However, the exact mechanism of action of maternal vitamin D
deﬁciency on fetal growth indices is not clear. Neonatal vitamin D
level correlates well with maternal vitamin D level [23].
Osteoblasts have 1,25(OH)D receptors, and low 25(OH)D and/or
1,25(OH)D in the fetus results in decreased osteoblast activity,
reducing bone growth [24]. Fetal vitamin D deﬁciency can also
stimulate fetal parathyroid hormone and parathyroid-hormone-
related protein activity, leading to decreased cortical bone growth
[25].
A few intervention studies have been undertaken to investigate
the effect of vitamin D administration on fetal growth [26–28].
Some of these studies found no effect on fetal growth, while others
reported an improvement in fetal growth indices. Given the high
prevalence of vitamin D deﬁciency in Iran and the low number of
intervention studies, this clinical trial was designed to investigate
the effect of vitamin D treatment during the third trimester on fetal
growth and maternal weight gain in women with vitamin D
deﬁciency or insufﬁciency.
2. Materials and methods
This open-label randomized clinical trial was undertaken in
Qazvin, Iran, from December 2011 to March 2012. It was approved
by the Ethics Committee of Qazvin University of Clinical Science.
Details of the study were explained to the participants, and written
consent was obtained before participation. This study was
registered retrospectively on www.irct.ir (Registration number:
201205119491N2).
The primary outcome was the effect of treatment of maternal
vitamin D deﬁciency or insufﬁciency on newborn length at birth.
Secondary outcomes were the effect of treatment on other fetal
growth indices (head circumference and weight) and maternal
weight gain during pregnancy. Vitamin D deﬁciency and insufﬁ-
ciency were deﬁned as serum 25(OH)D level <20 ng/ml and 20–
30 ng/ml, respectively [29]. In total, 160 pregnant women (24–26
weeks of gestation) who attended an obstetric clinic for antenatal
care were investigated. Inclusion criteria were: gestational age of
24–26 weeks, singleton pregnancy and body mass index (BMI) of
19–26 kg/m2. Exclusion criteria at study enrolment were: diabetes
before pregnancy, chronic hypertension, history of repeated
abortion, rheumatoid arthritis, parathyroid disorders, hepatic or
renal diseases, and use of aspirin, anticonvulsive and immunosup-
pressive drugs. Subjects who developed gestational diabetes,
severe pre-eclampsia, fetal anomaly, preterm delivery (before 37
weeks of gestation), oligohydramnios or polyhydramnios were
excluded at the end of the study before statistical analyses were
performed.
Initially, blood samples were collected from pregnant women to
measure the serum vitamin D level; once the results were
obtained, those with vitamin D deﬁciency or insufﬁciency [serum
25(OH)D <30 ng/ml] were included in the study. Participants were
assigned at random into the intervention group or the control
group. Allocation was concealed and randomization was per-
formed using computer-generated random numbers. Assignment
into groups was performed by an obstetrician responsible for
antenatal care. This study was conducted in accordance with the
Declaration of Helsinki, and all procedures involving human
subjects were approved by the Ethics Committee of Qazvin
University of Medical Science.
Women in the control group received a multivitamin contain-
ing 400 IU vitamin D3 plus 200 mg elemental calcium each day
until delivery. Women in the intervention group received a weekly
dose of 50,000 IU oral vitamin D3 for 8 weeks (from 26 to 28 weeks
of pregnancy) as well as the drug regimen (multivitamin and
elemental calcium) given to the control group. The participants
were visited once every 2 weeks during the second trimester and
once a week in the third trimester; parameters such as weight,
blood pressure, uterine fundal length, and use of vitamin D
supplement and multivitamin were measured or checked.
Following delivery, maternal and cord blood samples (5 ml) were
taken after clamping and sent to the hospital laboratory to be
centrifuged and kept frozen until use. Serum vitamin D was
determined using a commercial enzyme-linked immunosorbent
assay kit (Euroimmun, Lubeck, Germany). The intra-assay and
interassay coefﬁcients of variation for 25(OH)D were 3.3% and
6.7%, respectively. On admission for labor, maternal weight,
neonatal weight, neonatal length and neonatal head circumference
were measured. Neonatal weight and length were measured using
a calibrated instrument (Seca Medical Measuring Systems). Head
circumference (largest occipitofrontal circumference) was mea-
sured to the nearest 1 mm using an unstretchable tape measure.
Anthropometric measurements were taken by a nurse who was
blinded to the patient’s group.
Data were presented as frequency tables, diagrams and
numerical indices. Chi-squared test, Fisher’s exact test, ANCOVA
test and t-test were used for data analysis. A multivariate
regression analysis was performed to examine the independent
effect of maternal vitamin D level on fetal growth indices.
3. Results
Vitamin D deﬁciency or insufﬁciency was found in 130 out of
160 pregnant women (81%). During the study, one case of
gestational diabetes and one case of premature rupture of
membranes occurred in the intervention group. Ten women in
the control group and nine women in the intervention group were
lost to follow-up as they gave birth in places that were difﬁcult to
access (Fig. 1).
Complete results were obtained for 54 women in the control
group and 55 women in the intervention group. Mean gravidity,
gestational age at delivery, BMI, sun exposure time and serum
vitamin D level did not differ signiﬁcantly between the two groups
(Table 1). Gestational age at delivery was similar in both groups.
At delivery, maternal serum vitamin D level was signiﬁcantly
higher in the intervention group compared with the control group
(Table 2). Mean neonatal length was 0.8 cm more in the
intervention group compared with the control group (p = 0.01)
(Table 2), and mean neonatal head circumference was also higher
in the intervention group (p = 0.001) (Table 2). Finally, on average,
neonates in the intervention group weighed 170.2 g more than
neonates in the control group (p = 0.01) (Table 2). Women in the
intervention group gained more weight during pregnancy
compared with women in the control group (p = 0.006)
(Table 2). A multivariate regression analysis was performed for
each growth index and maternal weight gain to investigate
independent correlation of fetal growth indices and maternal
weight gain with maternal vitamin D level and other maternal
factors (including age, BMI, gravidity, gestational age at delivery).
Maternal vitamin D level and gestational age at delivery were
independently correlated with neonatal length, weight and head
circumference (Table 3). Maternal weight gain was independently
correlated with serum vitamin D level, and inversely correlated
with maternal BMI at enrolment.
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Fig. 1. CONSORT ﬂowchart of participants.
Table 1
Baseline demographic and reproductive variables by group*.
Control group Intervention group
Total Participants who completed study Total Participants who completed study
Number 65 54 65 55
Age (years) 27.4  4.6 27.6  4.6 26.9  4.7 27.0  4.6
Sunlight exposure <30 min/day (%) 50.7% 48.1% 49.2% 47.2%
Body mass index (kg/m2) 24.5  2.4 24.4  2.5 24.5  2.5 24.2  2.5
Vitamin D level (ng/ml) 17.6  4.8 17.5  4.8 15.9  5.6 15.8  5.6
Vitamin D deﬁciency (<20 ng/ml) (%) 66.1% 62.9% 67.6% 67.3%
Vitamin D insufﬁciency (20–30 ng/ml) (%) 33.9% 37.1% 32.4% 32.7%
Values are given as mean  standard deviation unless otherwise indicated.
* There were no signiﬁcant differences in baseline characteristics between the two groups.
Table 2
Comparison of maternal and neonatal serum vitamin D levels and anthropometric indices of the two groups at the end of the study.
Variable Control group (95% CI) Intervention group (95% CI) Mean difference (95% CI) p-value
Maternal vitamin D (ng/ml)a 15.9  6.6
(14.1–17.8)
47.8  11.1
(44.8–50.8)
31.8
(28.3–35.3)
Maternal vitamin D >30 ng/ml (%) 3% 100% 0.0001b
Neonatal vitamin D (ng/ml)a 10.9  4.4
(9.4–11.9)
27.7  5.2
(26.3–29.1)
17.0
(15.2–18.9)
0.001c
Neonatal vitamin D >30 ng/ml (%) 0% 32.7% 0.0001d
Neonatal length (cm)a 48.2  1.7
(47.7–48.6)
49.0  1.6
(48.6–49.4)
0.8
(0.18–1.4)
0.01c
Neonatal head circumference (cm)a 35.3  1.0
(35.0–35.6)
35.9  0.7
(35.7–36.1)
0.6
(0.2–0.9)
0.001c
Neonatal weight (g)a 3258.8  328.2
(3169.2–3348.4)
3429.0  351.9
(3333.9–3524.2)
170.2
(40.9–299.4)
0.01c
Maternal weight gain during pregnancy (kg)a 11.7  2.7
(11.0–12.5)
13.3  2.4
(12.6–13.9)
1.5
(0.5–2.4)
0.006e
CI, conﬁdence interval.
a Values are given as mean  standard deviation.
b Signiﬁcant difference on Chi-squared test.
c Signiﬁcant difference on t-test.
d Signiﬁcant difference on Fisher’s exact test.
e Signiﬁcant difference on ANCOVA test; maternal weight gain adjusted for body mass index before intervention.
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No cases of neonatal death or congenital malformations
occurred in either group. One neonate in the control group was
small for gestational age, and all neonates in the intervention
group were of normal weight.
4. Comments
This study found that treatment of pregnant women with
vitamin D deﬁciency or insufﬁciency resulted in improved fetal
growth indices (length, head circumference and weight) and
greater maternal weight gain during pregnancy. In addition,
maternal vitamin D level was signiﬁcantly independently corre-
lated with neonatal length, weight and head circumference.
Most studies undertaken on the association between maternal
vitamin D level and fetal growth indices have been descriptive
cross-sectional studies, and the results have been inconsistent.
Some of these studies found no correlation between vitamin D
level and bone density or anthropometric characteristics [21],
whereas other studies found that fetal growth indices were lower
in cases where the mother was vitamin D deﬁcient [17]. Few
clinical trials have been undertaken regarding the effect of vitamin
D administration in pregnant women on fetal growth. Kalra et al.
reported improved anthropometric characteristics (length, weight,
head circumference and fontanelle size) in neonates following
administration of a single dose (1500 mg) of vitamin D during the
second trimester, or two doses (3000 mg) of vitamin D during the
second and third trimesters [26]. In another study by Marya et al.
on pregnant women who received two doses of vitamin D
(600,000 U) during the seventh and eighth months of gestation,
neonatal weight and serum calcium and phosphorus levels were
higher, but alkaline phosphatase levels were lower [27]. On the
contrary, Mallet et al. investigated the effect of vitamin D
administration on biochemical parameters and weight in three
groups of pregnant women [Group I: vitamin D (5 mg) at 7 months
of gestation; Group II: vitamin D (1000 U/day); Group III: no
vitamin D administration], and found no signiﬁcant difference in
neonatal weight between the groups [28].
The discrepancies in clinical trial results could be associated
with differences in the baseline vitamin D levels of the pregnant
women, and different doses of vitamin D administered. In the
present study, the main inclusion criterion for pregnant women
was maternal serum 25(OH)D level <30 ng/ml, whereas in other
studies, this measure was not taken into account. The inclusion of
pregnant women with a normal level of vitamin D in clinical trials
could dilute the results of the study and eventually lead to an
insigniﬁcant difference in the ﬁndings.
The present study had strengths and weaknesses. Strengths
included the intervention study design, recruitment in a single
season, and the inclusion criterion of vitamin D deﬁciency or
insufﬁciency. A limitation of the present study was the lack of use
of a placebo, although the investigator who evaluated the fetal
growth indices was blind to the mothers’ group allocation.
In conclusion, this study showed that treatment of pregnant
women with vitamin D deﬁciency or insufﬁciency improves fetal
growth indices (length, weight and head circumference) and
increases maternal weight gain during pregnancy.
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